Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Cipla
Daiichi Sankyo
UBS
Colorcon
Chubb
US Department of Justice
Express Scripts

Generated: May 27, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,124,630

« Back to Dashboard

Summary for Patent: 8,124,630
Title:.omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Inventor(s): Riedl; Bernd (Wuppertal, DE), Dumas; Jacques (Orange, CT), Khire; Uday (Hamden, CT), Lowinger; Timothy B. (Nishinomiya, JP), Scott; William J. (Guilford, CT), Smith; Roger A. (Madison, CT), Wood; Jill E. (North Haven, CT), Natero; Reina (Hamden, CT)
Assignee: Bayer Healthcare LLC (Tarrytown, NY)
Application Number:09/993,647
Patent Claims: 1. A method for the treatment of carcinoma of the lung, pancreas, thyroid, bladder or colon in a human or animal in need thereof comprising administering an effective amount of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-carbamoyl-4-pyridyloxy)ph- enyl)urea of the formula: ##STR00186## N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyr- idyloxy)phenyl)urea of the formula: ##STR00187## or a pharmaceutically acceptable salt thereof.

2. A method for the treatment of myeloid leukemia in a human in need thereof comprising administering an effective amount of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-carbamoyl-4-pyridyloxy)ph- enyl)urea of the formula: ##STR00188## N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyr- idyloxy)phenyl)urea of the formula: ##STR00189## or a pharmaceutically acceptable salt thereof.

3. A method of claim 1 for the treatment of carcinoma of the lung in a human in need thereof.

4. A method of claim 1 for the treatment of carcinoma of the pancreas in a human in need thereof.

5. A method of claim 1 for the treatment of carcinoma of the thyroid in a human in need thereof.

6. A method of claim 1 for the treatment of carcinoma of the bladder in a human in need thereof.

7. A method of claim 1 for the treatment of carcinoma of the colon in a human in need thereof.

8. A method for the treatment of carcinoma of the lung, pancreas, thyroid, bladder or colon in a human or animal in need thereof comprising administering an effective amount of a tosylate salt of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyr- idyloxy)phenyl)urea of the formula: ##STR00190##

9. A method for the treatment of myeloid leukemia in a human in need thereof comprising administering an effective amount of a tosylate salt of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-- pyridyloxy)phenyl)urea of the formula: ##STR00191##

10. A method of claim 8 for the treatment of carcinoma of the lung in a human in need thereof.

11. A method of claim 8 for the treatment of carcinoma of the pancreas in a human in need thereof.

12. A method of claim 8 for the treatment of carcinoma of the thyroid in a human in need thereof.

13. A method of claim 8 for the treatment of carcinoma of the bladder in a human in need thereof.

14. A method of claim 8 for the treatment of carcinoma of the colon in a human in need thereof.

15. A method for the treatment of villous colon adenoma comprising administering an effective amount of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-carbamoyl-4-pyridyloxy)ph- enyl)urea of the formula: ##STR00192## N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyr- idyloxy)phenyl)urea of the formula: ##STR00193## or a pharmaceutically acceptable salt thereof.

16. A method for the treatment of villous colon adenoma comprising administering an effective amount of a tosylate salt of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyr- idyloxy)phenyl)urea of the formula: ##STR00194##

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Cerilliant
Deloitte
Daiichi Sankyo
Dow
UBS
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.